bioMerieux S.A.
Stock Exchange Euronext Paris
EPS
EUR2.17
Market Cap
EUR8.57 B
Shares Outstanding
118.36 M
Public Float
38.97 M

Profile

Address
376, chemin de l'Orme
Marcy l'Etoile Rhone-Alpes 69280
France
Employees -
Website http://www.biomerieux.com
Updated 07/08/2019
bioMérieux SA engages in the provision of diagnostic solutions which determine the source of disease and contamination. The company provides clinical solutions such as antimicrobial resistance, C. difficile infection, human immunodeficiency virus, and emergency department patient management.

Financials

View All
Created with Highcharts 5.0.14bioMerieux S.A.Net Income. Fiscal year is January-December. All values EUR Millions.164164135135111111179179238238257257201320142015201620172018050100150200250300
Created with Highcharts 5.0.14bioMerieux S.A.Sales/Revenue. Fiscal year is January-December. All values EUR Millions.1 5881 5881 6981 6981 9651 9652 1032 1032 2882 2882 4212 421201320142015201620172018050010001500200025003000

Alexandre Mérieux
Chairman & Chief Executive Officer
Jean-Luc Bélingard
Director